CSPC Pharmaceutical Group Limited

OTCPK:CHJT.F Stock Report

Market Cap: US$7.6b

CSPC Pharmaceutical Group Management

Management criteria checks 3/4

CSPC Pharmaceutical Group's CEO is Cuilong Zhang, appointed in May 2022, has a tenure of 2.5 years. total yearly compensation is CN¥13.47M, comprised of 5.1% salary and 94.9% bonuses, including company stock and options. directly owns 0.043% of the company’s shares, worth $3.27M. The average tenure of the management team and the board of directors is 2.5 years and 7.7 years respectively.

Key information

Cuilong Zhang

Chief executive officer

CN¥13.5m

Total compensation

CEO salary percentage5.1%
CEO tenure2.5yrs
CEO ownership0.04%
Management average tenure2.5yrs
Board average tenure7.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Cuilong Zhang's remuneration changed compared to CSPC Pharmaceutical Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

CN¥5b

Jun 30 2024n/an/a

CN¥6b

Mar 31 2024n/an/a

CN¥6b

Dec 31 2023CN¥13mCN¥693k

CN¥6b

Sep 30 2023n/an/a

CN¥6b

Jun 30 2023n/an/a

CN¥6b

Mar 31 2023n/an/a

CN¥6b

Dec 31 2022CN¥11mCN¥693k

CN¥6b

Sep 30 2022n/an/a

CN¥6b

Jun 30 2022n/an/a

CN¥6b

Mar 31 2022n/an/a

CN¥6b

Dec 31 2021CN¥9mCN¥693k

CN¥6b

Sep 30 2021n/an/a

CN¥6b

Jun 30 2021n/an/a

CN¥6b

Mar 31 2021n/an/a

CN¥5b

Dec 31 2020CN¥9mCN¥693k

CN¥5b

Sep 30 2020n/an/a

CN¥4b

Jun 30 2020n/an/a

CN¥4b

Mar 31 2020n/an/a

CN¥4b

Dec 31 2019CN¥7mCN¥693k

CN¥4b

Sep 30 2019n/an/a

CN¥4b

Jun 30 2019n/an/a

CN¥3b

Mar 31 2019n/an/a

CN¥3b

Dec 31 2018CN¥4mCN¥298k

CN¥3b

Compensation vs Market: Cuilong's total compensation ($USD1.86M) is below average for companies of similar size in the US market ($USD7.94M).

Compensation vs Earnings: Cuilong's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Cuilong Zhang (55 yo)

2.5yrs

Tenure

CN¥13,472,000

Compensation

Mr. Cuilong Zhang has been the Vice Chairman of CSPC Pharmaceutical Group Ltd since May 21, 2019 and serves as its Chief Executive Officer since May 27, 2022. He was Rotating Chief Executive Officer of CSP...

Leadership Team

NamePositionTenureCompensationOwnership
Dongchen Cai
Executive Chairman27.6yrsCN¥26.68m24.17%
$ 1.8b
Cuilong Zhang
Vice-Chairman & CEO2.5yrsCN¥13.47m0.043%
$ 3.3m
Chunlei Li
Executive Director & Chief Scientist6.9yrsCN¥9.42m0.039%
$ 2.9m
Weidong Pan
Executive Directorno dataCN¥4.92m0.013%
$ 981.1k
Huaiyu Wang
Executive Directorno dataCN¥5.74m0.013%
$ 981.1k
Zhenguo Wang
Executive Directorno dataCN¥4.90m0.013%
$ 981.1k
Hao Jiang
Executive Directorno dataCN¥4.02m0.026%
$ 2.0m
Xin Cai
Group Executive Presidentno datano datano data
Bing Yao
Executive Directorless than a yearno datano data
Yongjun Liu
Executive president & President of Global Research and Developmentless than a yearno datano data
Tai On Lo
Company Secretary3.8yrsno datano data

2.5yrs

Average Tenure

54.5yo

Average Age

Experienced Management: CHJT.F's management team is considered experienced (2.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Dongchen Cai
Executive Chairman27.6yrsCN¥26.68m24.17%
$ 1.8b
Cuilong Zhang
Vice-Chairman & CEO6.3yrsCN¥13.47m0.043%
$ 3.3m
Chunlei Li
Executive Director & Chief Scientist6.9yrsCN¥9.42m0.039%
$ 2.9m
Weidong Pan
Executive Director18.1yrsCN¥4.92m0.013%
$ 981.1k
Huaiyu Wang
Executive Director14.1yrsCN¥5.74m0.013%
$ 981.1k
Zhenguo Wang
Executive Director12.8yrsCN¥4.90m0.013%
$ 981.1k
Hao Jiang
Executive Director4yrsCN¥4.02m0.026%
$ 2.0m
Xin Cai
Group Executive Presidentless than a yearno datano data
Bing Yao
Executive Directorless than a yearno datano data
Chun Kwok Au
Independent Non-Executive Director3.8yrsCN¥340.00kno data
Bo Wang
Independent Non-Executive Director11.9yrsCN¥142.00kno data
Chuan Chen
Independent Non-Executive Director8.4yrsCN¥142.00kno data

7.7yrs

Average Tenure

54.5yo

Average Age

Experienced Board: CHJT.F's board of directors are considered experienced (7.7 years average tenure).